Norethindrone

Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.

Cross Reference

Introduction

To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Norethindrone?

Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Norethindrone

MeSH term MeSH ID Detail
Arteriosclerosis D001161 86 associated lipids
Body Weight D001835 333 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Total 3

PubChem Associated disorders and diseases

What pathways are associated with Norethindrone

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Norethindrone?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Norethindrone?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Norethindrone?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Norethindrone?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Norethindrone?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Norethindrone

Download all related citations
Per page 10 20 50 100 | Total 3869
Authors Title Published Journal PubMed Link
Friedrich E et al. Effects of 0.5 mg. of lynestrenol daily on hypothalamic-pituitary-ovarian function. 1975 Am. J. Obstet. Gynecol. pmid:1146929
Benagiano G and Gabelnick HL Biodegradable systems for the sustained release of fertility-regulating agents. 1979 J. Steroid Biochem. pmid:114715
Sipilä S et al. Effects of hormone replacement therapy and high-impact physical exercise on skeletal muscle in post-menopausal women: a randomized placebo-controlled study. 2001 Clin. Sci. pmid:11473488
Watanabe H Effect of 17alpha-ethinylestradiol on biliary excretion of bile acids. 1975 Biochim. Biophys. Acta pmid:1148281
Sanderson JE et al. Anti-ischemic action of estrogen-progestogen continuous combined hormone replacement therapy in postmenopausal women with established angina pectoris: a randomized, placebo-controlled, double-blind, parallel-group trial. 2001 J. Cardiovasc. Pharmacol. pmid:11486242
Briggs MH and Briggs M Serum activity of lysosomal enzymes in relationship to contraceptive steroid dose. 1975 Curr Med Res Opin pmid:1149488
Rugarn O et al. Progesterone and norethisterone have different effects on tachykinin-like immunoreactivity in rat cortex and striatum. 2001 Regul. Pept. pmid:11495683
Maier WE and Herman JR Pharmacology and toxicology of ethinyl estradiol and norethindrone acetate in experimental animals. 2001 Regul. Toxicol. Pharmacol. pmid:11502156
Hilbert J et al. Evaluation of interaction between fluconazole and an oral contraceptive in healthy women. 2001 Obstet Gynecol pmid:11506836
Goldsmith NF and Johnston JO Bone mineral: effects of oral contraceptives, pregnancy, and lactation. 1975 J Bone Joint Surg Am pmid:1150709
Larrea F et al. A-ring reduced metabolites of 19-nor synthetic progestins as subtype selective agonists for ER alpha. 2001 Endocrinology pmid:11517155
pmid:11521119
Skarda J Detection of estrogenicity by bioassay on the mouse mammary gland in vivo. 2001 Physiol Res pmid:11521738
Beck P et al. Effect of contraceptive steroids on arginine-stimulated glucagon and insulin secretion in women: I-Lipid physiology. 1975 Metab. Clin. Exp. pmid:1152675
Simon JA and Symons JP Unscheduled bleeding during initiation of continuous combined hormone replacement therapy: a direct comparison of two combinations of norethindrone acetate and ethinyl estradiol to medroxyprogesterone acetate and conjugated equine estrogens. 2001 Sep-Oct Menopause pmid:11528357
Wihlbäck AC et al. Influence of postmenopausal hormone replacement therapy on platelet serotonin uptake site and serotonin 2A receptor binding. 2001 Obstet Gynecol pmid:11530128
pmid:11531333
SendaÄŸ F et al. Mammographic density changes during different postmenopausal hormone replacement therapies. 2001 Fertil. Steril. pmid:11532462
Gruschke A and Kuhl H Validity of radioimmunological methods for determining free testosterone in serum. 2001 Fertil. Steril. pmid:11532484
Endrikat J et al. Multicenter, comparative study of cycle control, efficacy and tolerability of two low-dose oral contraceptives containing 20 microg ethinylestradiol/100 microg levonorgestrel and 20 microg ethinylestradiol/500 microg norethisterone. 2001 Contraception pmid:11535206
Wiese J [Drug information. Mini-pills]. 1975 Ugeskr. Laeg. pmid:1154531
pmid:11562270
Campagnoli C et al. Effect of conjugated estrogens on free IGF-I? 2001 Fertil. Steril. pmid:11570370
Berenson AB et al. A prospective, controlled study of the effects of hormonal contraception on bone mineral density. 2001 Obstet Gynecol pmid:11576570
Kondoh Y et al. A longitudinal study of disturbances of the hypothalamic-pituitary-adrenal axis in women with progestin-negative functional hypothalamic amenorrhea. 2001 Fertil. Steril. pmid:11591409
Nordin BE et al. Bone densitometry in clinical practice: longitudinal measurements at three sites in postmenopausal women on five treatments. 2001 Climacteric pmid:11594313
Sørensen MB et al. Obesity and sarcopenia after menopause are reversed by sex hormone replacement therapy. 2001 Obes. Res. pmid:11595778
Mishell DR et al. Initial clinical studies of intravaginal rings containing norethindrone and norgestrel. 1975 Contraception pmid:1164845
Hampton RM et al. Comparison of a novel norgestimate/ethinyl estradiol oral contraceptive (Ortho Tri-Cyclen Lo) with the oral contraceptive Loestrin Fe 1/20. 2001 Contraception pmid:11672549
Ambrus G et al. Microbiological 1 alpha-hydroxylation of norethisterone. 1975 Steroids pmid:1167432
Junquera F et al. A multicenter, randomized, clinical trial of hormonal therapy in the prevention of rebleeding from gastrointestinal angiodysplasia. 2001 Gastroenterology pmid:11677198
Wadsworth PF et al. Treatment of rhesus monkeys (Macaca mulatta) with intravaginal rings impregnated with either progesterone or norethisterone. 1979 Contraception pmid:116799
Prasad AS et al. Effect of oral contraceptive agents on nutrients: II. Vitamins. 1975 Am. J. Clin. Nutr. pmid:1168019
Posaci C et al. Effects of HRT on serum levels of IGF-I in postmenopausal women. 2001 Maturitas pmid:11684375
Van Vliet H et al. Biphasic versus monophasic oral contraceptives for contraception. 2001 Cochrane Database Syst Rev pmid:11687135
Van Vliet H et al. Biphasic versus triphasic oral contraceptives for contraception. 2001 Cochrane Database Syst Rev pmid:11687185
Darko DA et al. Glycaemic control and plasma lipoproteins in menopausal women with Type 2 diabetes treated with oral and transdermal combined hormone replacement therapy. 2001 Diabetes Res. Clin. Pract. pmid:11689270
pmid:11703152
Høibraaten E et al. Hormone replacement therapy and acquired resistance to activated protein C: results of a randomized, double-blind, placebo-controlled trial. 2001 Br. J. Haematol. pmid:11703344
pmid:11704183
Clinicopathological conference. A patient's life. 1975 Br Med J pmid:1170920
Wiegratz I et al. [Cross-over comparison of the pharmacokinetics of estradiol during hormone replacement therapy with estradiol valerate or micronized estradiol]. 2001 Zentralbl Gynakol pmid:11709743
Harwood B and Mishell DR Contraceptive vaginal rings. 2001 Semin. Reprod. Med. pmid:11727180
Haines CJ et al. The effect of continuous combined hormone replacement therapy on arterial reactivity in postmenopausal women with established angina pectoris. 2001 Atherosclerosis pmid:11730828
Bruhat M et al. Effective bleeding control and symptom relief by lower dose regimens of continuous combined hormone replacement therapy: a randomized comparative dose-ranging study. 2001 Maturitas pmid:11731187
Herkert O et al. Sex steroids used in hormonal treatment increase vascular procoagulant activity by inducing thrombin receptor (PAR-1) expression: role of the glucocorticoid receptor. 2001 Circulation pmid:11733402
Weeke J and Hansen AP Serum tsh and serum t3 levels during normal menstrual cycles and during cycles on oral contraceptives. 1975 Acta Endocrinol. pmid:1173500
Endrikat J et al. Impact of oral contraceptive use on APC-resistance: a prospective, randomized clinical trial with three low-dose preparations. 2001 Contraception pmid:11747870
Yamasaki K et al. Comparison of reporter gene assay and immature rat uterotrophic assay of twenty-three chemicals. 2002 Toxicology pmid:11750080
Mueck AO et al. The effects of postmenopausal hormone replacement therapy and oral contraceptives on the endogenous estradiol metabolism. 2001 Horm. Metab. Res. pmid:11753761